Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hubert Wysogląd
Observed name:
Hubert Wysoglad
Institution:
Szpital Uniwersytecki w Krakowie
Observed institutions:
Jagiellonian University,
Medical University of South Carolina,
Medical University of Warsaw,
National Medical Research Center for Hematology,
Szpital Uniwersytecki w Krakowie
ORCID:
0000-0003-2947-1116
Observed ORCID:
0000-0003-2947-1116
OpenAlex ID:
A5032072467
Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience
2022
·
Elżbieta Szczepanek
, Ositadima Chukwu
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
13
High Level of CD8+PD-1+ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation
2024
·
Paulina Kwaśnik
, Joanna Zaleska
, et al.
·
Cells
·
8
PDF
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry
2022
·
Joanna Góra-Tybor
, Aleksandra Gołos
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
Long-Term Outcomes of Imatinib Real-Life Treatment for Chronic Myeloid Leukemia- a 20-Year Review
2020
·
Elzbieta Szczepanek
, Ositadima Chukwu
, et al.
·
Blood
·
3
The PD1 Molecule May Contribute to Lower Treatment-Free Remission Rates in Patients with Chronic Myeloid Leukemia with the e13a2 Transcript
2025
·
Paulina Kwaśnik
, Michał Kiełbus
, et al.
·
Journal of Clinical Medicine
·
1
POSTER: AML-384 Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia
2023
·
Hubert Wysogląd
, Katarzyna Krawczyk
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-384 Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia
2023
·
Hubert Wysogląd
, Katarzyna Krawczyk
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Impact of the Covid-19 Pandemic on Quality of Life of Patients with CML
2021
·
Hubert Wysoglad
, Elzbieta Szczepanek
, et al.
·
Blood
PDF
Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry
2019
·
Joanna Gora Tybor
, Aleksandra Golos
, et al.
·
Blood
Show more works
View as search
Works count:
9
Citation count:
28
H-index:
3
I10-index:
1
Year
Topic
Type